TREATMENT INFORMATION
Pluvicto for Prostate Cancer: Treatment Information
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is a targeted radioactive therapy for eligible patients with PSMA-positive metastatic prostate cancer.
Start with a specialist review.
Ask Fusion about current availability of this therapy and the referral records needed. Treatment requires an individual clinical assessment; reading this page or requesting information does not confirm eligibility.
Why your doctor may recommend it.
Eligibility depends on the current prescribing information, cancer setting, PSMA imaging, prior treatment, laboratory findings, and specialist review. Current FDA indications include selected metastatic prostate cancer settings.
Learn more: Pluvicto indications: FDA
Pluvicto is not appropriate for every patient with prostate cancer. It can cause serious adverse effects; eligibility and the treatment plan require specialist review.
Preparing for your visit.
Before your appointment
Have your oncology referral, pathology, PSMA imaging, prior treatments, and recent laboratory results available. Ask Fusion to confirm current operational availability.
What to expect
If treatment is recommended and available, your care team will explain dosing visits, monitoring, possible side effects, and radiation precautions.
Your referral, results & cost.
Referral information
Have the requested study or consultation, your doctor’s order if provided, clinical notes, and relevant prior imaging available. Call to confirm what is required.
Timing & results
Ask our team for your full visit schedule and expected report timing. Your referring clinician will discuss the findings and next steps with you.
Insurance & estimates
Request an estimate for the exact study or therapy. Ask about authorization, network status, and what your plan may require. Coverage and out-of-pocket costs vary.
Questions patients often ask.
Is this the right option for my diagnosis?
Your referring clinician and the imaging or treatment specialist assess the clinical question, prior records, and relevant risks. A scan or therapy is not suitable for everyone.
How long will my visit take?
The schedule depends on your specific protocol, including preparation, any waiting period, imaging, or treatment monitoring. Ask our team before arranging transportation.
Should I change my medicines?
Do not stop or change medicines on your own. Share your complete medication list and ask for instructions specific to your study or therapy.
What should I tell the team before my appointment?
Tell us if you are pregnant, may be pregnant, or are breastfeeding. Discuss allergies, relevant medical conditions, and any difficulty lying still or feeling comfortable in a scanner.
Related information.
PSMA PET/CT imagingLet’s help you take the next step.
Call our Las Vegas team to discuss the requested study, a referral, or a cost estimate.
Call (702) 720-4392